Clinical Trials in San Francisco

Showing 5421-5440 of 12,991 trials

Discovering Factors in the Clinical Study Journey of Patients With OCD

NCT05881356

This research aims to collect comprehensive data on the clinical trial experience of OCD patients. Its goal is to identify the factors that limit patients' ability to join or complete a trial successfully. Clinical trial participation often favors specific demographic groups, and limited research exists on the impact of trial attributes on participation. Therefore, this study aims to analyze data from various demographic groups and identify any recurring trends that could provide valuable insights for future OCD patients.

OCDObsessive-Compulsive Disorder

Power Life Sciences Inc.500 participantsStarted Jun 2024

San Francisco, California, United States

TERMINATEDPhase 1< 1 mile

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

NCT05077423

Pediatric patients (\<21 years at study entry) with relapsed or refractory acute myeloid leukemia (AML) will be treated with CD33\*CD3 a bispecific antibody to investigate the safety and tolerability of the drug.

AML, Childhood

Y-mAbs Therapeutics3 participantsStarted May 2022

Birmingham, Alabama, United States • Orange, California, United States • San Francisco, California, United States +10 more locations

Discovering Factors in the Clinical Study Journey of Patients With OCD

A Phase 1 Trial of CD33xCD3 BsAb in Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia

Find Trials by Condition in San Francisco

Rate of Atrial Fibrillation Through 12 Months in Patients With Recent Ischemic Stroke of Presumed Known Origin

Therapeutic Antibodies Against Prion Diseases From PRNP Mutation Carriers

Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

Dimethyl Fumarate (DMF) Observational Study

S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia

Digital Therapeutic for Adolescent Depressive Symptoms in Cardiology and Gastroenterology

Stay Well at Home: a Text-messaging Study Social Distancing

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Single-Ascending Dose Study of JK07 in Subjects With HFpEF

Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis

A 3-week Study Investigating Patient Use and Functionality of Formoterol in a Novel Inhalation Device in Patients With Asthma

Diagnostic Imaging Study for the Melanoma Advanced Imaging Dermatoscope (mAID)

Study to Evaluate the Efficacy and Safety of Oral Difelikefalin (CR845) for Moderate to Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)

Study of Diroximel Fumarate in the Real-World Setting

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

Comparing NUC-1031 Plus Cisplatin to Gemcitabine Plus Cisplatin in Patients With Advanced Biliary Tract Cancer

Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis